305
Participants
Start Date
December 8, 2020
Primary Completion Date
June 15, 2022
Study Completion Date
June 15, 2022
Rosuvastatin
Pharmaceutical form:Tablet Route of administration: Oral
SPC ezetimibe/rosuvastatin
Pharmaceutical form:Tablet Route of administration: Oral
Rosuvastatin active capsule
Pharmaceutical form:Capsule Route of administration: Oral
Placebo
Pharmaceutical form:Tablet Route of administration: Oral
Placebo
Pharmaceutical form:Capsule Route of administration: Oral
Investigational Site Number :1560001, Beijing
Investigational Site Number :1560068, Beijing
Investigational Site Number :1560021, Beijing
Investigational Site Number :1560034, Shenyang
Investigational Site Number :1560015, Dalian
Investigational Site Number :1560045, Changchun
Investigational Site Number :1560067, Changchun
Investigational Site Number :1560014, Jilin
Investigational Site Number :1560057, Yanji
Investigational Site Number :1560010, Siping
Investigational Site Number :1560027, Shanghai
Investigational Site Number :1560066, Nanjing
Investigational Site Number :1560011, Zhenjiang
Investigational Site Number :1560003, Xuzhou
Investigational Site Number :1560065, Yangzhou
Investigational Site Number :1560020, Jinan
Investigational Site Number :1560037, Zibo
Investigational Site Number :1560002, Tianjin
Investigational Site Number :1560053, Tianjin
Investigational Site Number :1560061, Lishui
Investigational Site Number :1560060, Chongqing
Investigational Site Number :1560052, Changsha
Investigational Site Number :1560063, Zhuzhou
Investigational Site Number :1560019, Yueyang
Investigational Site Number :1560047, Wuhan
Investigational Site Number :1560009, Wuhan
Investigational Site Number :1560035, Wuhan
Investigational Site Number :1560005, Zhanjiang
Investigational Site Number :1560055, Nanning
Investigational Site Number :1560071, Liuzhou
Investigational Site Number :1560029, Haikou
Investigational Site Number :1560041, Chengdu
Investigational Site Number :1560022, Xi'an
Investigational Site Number :1560070, Xi'an
Investigational Site Number :1560064, Yinchuan
Investigational Site Number :1560033, Baotou
Investigational Site Number :1560025, Bengbu
Investigational Site Number :1560006, Hohhot
Investigational Site Number :1560007, Hohhot
Investigational Site Number :1560062, Yuncheng
Lead Sponsor
Sanofi
INDUSTRY